<DOC>
	<DOCNO>NCT01242020</DOCNO>
	<brief_summary>The purpose study test method imaging ( take picture ) abdomen ( belly ) , neck , thigh calf ( low leg ) area body , use ultrasound along drug make picture look clearer . Ultrasound type imaging use sound wave create picture inside human body . Two set picture take two different day see result time . DEFINITY® drug give intravenously ( vein ) . DEFINITY® approve FDA use ultrasound contrast agent ( make picture look clearer ) take picture heart . In study , DEFINITY® use take picture blood vessel abdomen ( belly ) , neck , thigh calf ( low leg ) . Since use DEFINITY® different use approve FDA , study perform FDA Investigational New Drug ( IND ) application .</brief_summary>
	<brief_title>Microvascular Flow Assessment Repeatability Study : The MARS Study</brief_title>
	<detailed_description />
	<criteria>1 . Men nonpregnant/lactating woman age 18 45 ; 2 . Lean ( BMI ≥18 ≤25 ) Obese grade III ( BMI &gt; 30 ≤35 ) 3 . Provide write informed consent sign HIPAA Waiver Authorization 4 . Be able willing follow instruction attend study visit Subjects must diagnose : 1 . Coronary artery disease 2 . Congestive heart failure 3 . Congenital heart disease ( Righttoleft , bidirectional , transient righttoleft cardiac shunt ) 4 . Hypersensitivity perflutren 5 . Renal disease 6 . Chronic obstructive pulmonary disease Asthma 7 . Primary secondary pulmonary hypertension 8 . Obstructive sleep apnea 9 . Thyroid disease 10 . Vasculitis 11 . Peripheral arterial disease . 12 . Cancer 13 . Any type immunosuppression 14 . Any active infection ( systemic underlying skin subcutaneous tissue ) . 15 . Taking prescribed medication hypertension , dyslipidemia diabetes . 16 . Current past smoking last 12 month . 17 . Positive urine pregnancy test 18 . Creatinine ( Cr ) 1.4 mg/dl screen evaluation 19 . Hemoglobin ( Hb ) less 10 mg/dl screen evaluation 20 . Aspartate Transaminase ( AST ) Alanine Transaminase ( ALT ) two fold upper limit normal screening evaluation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>